2m 2m 2m 2m 2m 2m 2m
Codexis (CDXS)
NASDAQ
$1.01+$0.01 (+1.30%)
Price as of Nov 11, 2026 7:43 PM EST- $109.5MMarket Cap
- -44.44%1-Year Change
- BiotechnologyIndustry
Codexis (CDXS)
$1.01+$0.01 (+1.30%)
CDXS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.00 | ||
Change | -$0.11 (-9.91%) | ||
Open | $1.12 | ||
High | $1.15 | ||
Low | $1.00 | ||
Previous Close | $1.11 | ||
Volume | 635,261 | ||
30-Day Average Volume | 845,750 | ||
1-Week Change | -7.41% | ||
1-Month Change | -29.08% | ||
1-Year Change | -44.44% | ||
3-Year Change | -39.76% | ||
5-Year Change | -97.39% | ||
Fundamentals | |||
Shares Outstanding | 109.5M | ||
Total Assets | $120.1M | ||
Market Cap | $109.5M | ||
Enterprise Value | $123.2M | ||
Period: QTR TTM FY | |||
Revenue | $13.2M | ||
Net Income | -$12.0M | ||
Free Cash Flow | -$10.5M | ||
EBIT | -$10.7M | ||
EBITDA | -$9.5M | ||
Net Working Capital | $48.4M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 3 | ||
P/E | -8 | ||
PEG | 0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue